BBA clinical最新文献

{"title":"Treatment of mild to moderate carpal tunnel syndrome in patients with diabetic neuropathy using low level laser therapy versus ultrasound controlled comparative study","authors":"Osama F. Ahmed ,&nbsp;Ahmed M. Elkharbotly ,&nbsp;Nahed Taha ,&nbsp;Ahmed B. Bekheet","doi":"10.1016/j.bbacli.2017.07.001","DOIUrl":"10.1016/j.bbacli.2017.07.001","url":null,"abstract":"<div><h3>Aim</h3><p>The aim of the present study was to investigate and compare between Low Level Laser Therapy (LLLT) and Ultrasound (US) in treatment of Carpal Tunnel Syndrome (CTS) using the advantage of application of treatment directly over the transverse carpal ligament, as well as over the course of the median nerve in the forearm simultaneously.</p></div><div><h3>Design</h3><p>Fifty patients (25–55<!--> <!-->years) with diabetic neuropathy, diagnosed as unilateral carpal tunnel syndrome participated in the study. They were equally divided and randomly assigned into two groups; each group consisted of 25 patients.</p></div><div><h3>Materials and methods</h3><p>Patients in group (A) received a program of IR Gallium Arsenide LLLT (wavelength 904<!--> <!-->nm, average power 20<!--> <!-->mW, laser probe 7<!--> <!-->mm diameter), with a total application of 4.8<!--> <!-->J, while patients in group (B) received a program of US (frequency 1<!--> <!-->MHz, power 1.0<!--> <!-->W/cm², pulsed mode 1:5).</p></div><div><h3>Results &amp; discussion</h3><p>The results of our study showed that there were no statistical significance differences (<em>P</em> <!-->&gt;<!--> <!-->0.05) were observed between the two groups. It was concluded that both low level laser (20<!--> <!-->mW power, 904<!--> <!-->nm Wavelength) and ultrasound (1.0<!--> <!-->w/cm² power, 1<!--> <!-->MHz frequency) are effective in the treatment of mild and moderate CTS patients.</p></div>","PeriodicalId":72344,"journal":{"name":"BBA clinical","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbacli.2017.07.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35360416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Signatures derived from increase in SHARPIN gene copy number are associated with poor prognosis in patients with breast cancer","authors":"Diane Ojo ,&nbsp;Maryam Seliman ,&nbsp;Damu Tang","doi":"10.1016/j.bbacli.2017.07.004","DOIUrl":"10.1016/j.bbacli.2017.07.004","url":null,"abstract":"<div><p>We report three signatures produced from <em>SHARPIN</em> gene copy number increase (GCN-Increase) and their effects on patients with breast cancer (BC). In the Metabric dataset (n<!--> <!-->=<!--> <!-->2059, cBioPortal), <em>SHARPIN</em> GCN-Increase occurs preferentially or mutual exclusively with mutations in <em>TP53</em>, <em>PIK3CA</em>, and <em>CDH1</em>. These genomic alterations constitute a signature (SigMut) that significantly correlates with reductions in overall survival (OS) in BC patients (n<!--> <!-->=<!--> <!-->1980; p<!--> <!-->=<!--> <!-->1.081e<!--> <!-->−<!--> <!-->6). Additionally, <em>SHARPIN</em> GCN-Increase is associated with 4220 differentially expressed genes (DEGs). These DEGs are enriched in activation of the pathways regulating cell cycle progression, RNA transport, ribosome biosynthesis, DNA replication, and in downregulation of the pathways related to extracellular matrix. These DEGs are thus likely to facilitate the proliferation and metastasis of BC cells. Additionally, through forward (FWD) and backward (BWD) stepwise variate selections among the top 160 downregulated and top 200 upregulated DEGs using the Cox regression model, a 6-gene (SigFWD) and a 50-gene (SigBWD) signature were derived. Both signatures robustly associate with decreases in OS in BC patients within the Curtis (n<!--> <!-->=<!--> <!-->1980; p<!--> <!-->=<!--> <!-->6.16e<!--> <!-->−<!--> <!-->11 for SigFWD; p<!--> <!-->=<!--> <!-->1.06e<!--> <!-->−<!--> <!-->10, for SigBWD) and TCGA cohort (n<!--> <!-->=<!--> <!-->817; p<!--> <!-->=<!--> <!-->4.53e<!--> <!-->−<!--> <!-->4 for SigFWD and p<!--> <!-->=<!--> <!-->0.00525 for SigBWD). After adjusting for known clinical factors, SigMut (HR 1.21, p<!--> <!-->=<!--> <!-->0.0297), SigBWD (HR 1.25, p<!--> <!-->=<!--> <!-->0.0263), and likely SigFWD (HR 1.17, p<!--> <!-->=<!--> <!-->0.062) remain independent risk factors of BC deaths. Furthermore, the proportion of patients positive for these signatures is significantly increased in ER<!--> <!-->−, Her2-enriched, basal-like, and claudin-low BCs compared to ER<!--> <!-->+ and luminal BCs. Collectively, these <em>SHARPIN</em> GCN-Increase-derived signatures may have clinical applications in management of patients with BC.</p></div>","PeriodicalId":72344,"journal":{"name":"BBA clinical","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbacli.2017.07.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35380962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit","authors":"Fernando Brites ,&nbsp;Maximiliano Martin ,&nbsp;Isabelle Guillas ,&nbsp;Anatol Kontush","doi":"10.1016/j.bbacli.2017.07.002","DOIUrl":"10.1016/j.bbacli.2017.07.002","url":null,"abstract":"<div><p>Uptake of low-density lipoprotein (LDL) particles by macrophages represents a key step in the development of atherosclerotic plaques, leading to the foam cell formation. Chemical modification of LDL is however necessary to induce this process. Proatherogenic LDL modifications include aggregation, enzymatic digestion and oxidation. LDL oxidation by one-electron (free radicals) and two-electron oxidants dramatically increases LDL affinity to macrophage scavenger receptors, leading to rapid LDL uptake and fatty streak formation.</p><p>Circulating high-density lipoprotein (HDL) particles, primarily small, dense, protein-rich HDL3, provide potent protection of LDL from oxidative damage by free radicals, resulting in the inhibition of the generation of pro-inflammatory oxidized lipids. HDL-mediated inactivation of lipid hydroperoxides involves their initial transfer from LDL to HDL and subsequent reduction to inactive hydroxides by redox-active Met residues of apolipoprotein A-I. Several HDL-associated enzymes are present at elevated concentrations in HDL3 relative to large, light HDL2 and can be involved in the inactivation of short-chain oxidized phospholipids. Therefore, HDL represents a multimolecular complex capable of acquiring and inactivating proatherogenic lipids.</p><p>Antioxidative function of HDL can be impaired in several metabolic and inflammatory diseases. Structural and compositional anomalies in the HDL proteome and lipidome underlie such functional deficiency. Concomitant normalization of the metabolism, circulating levels, composition and biological activities of HDL particles, primarily those of small, dense HDL3, can constitute future therapeutic target.</p></div>","PeriodicalId":72344,"journal":{"name":"BBA clinical","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbacli.2017.07.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35428580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Rapid diagnosis and intraoperative margin assessment of human lung cancer with fluorescence lifetime imaging microscopy","authors":"Mengyan Wang ,&nbsp;Feng Tang ,&nbsp;Xiaobo Pan ,&nbsp;Longfang Yao ,&nbsp;Xinyi Wang ,&nbsp;Yueyue Jing ,&nbsp;Jiong Ma ,&nbsp;Guifang Wang ,&nbsp;Lan Mi","doi":"10.1016/j.bbacli.2017.04.002","DOIUrl":"10.1016/j.bbacli.2017.04.002","url":null,"abstract":"<div><p>A method of rapidly differentiating lung tumor from healthy tissue is extraordinarily needed for both the diagnosis and the intraoperative margin assessment. We assessed the ability of fluorescence lifetime imaging microscopy (FLIM) for differentiating human lung cancer and normal tissues with the autofluorescence, and also elucidated the mechanism in tissue studies and cell studies. A 15-patient testing group was used to compare FLIM results with traditional histopathology diagnosis. Based on the endogenous fluorescence lifetimes of the testing group, a criterion line was proposed to distinguish normal and cancerous tissues. Then by blinded examined 41 sections from the validation group of other 16 patients, the sensitivity and specificity of FLIM were determined. The cellular metabolism was studied with specific perturbations of oxidative phosphorylation and glycolysis in cell studies. The fluorescence lifetime of cancerous lung tissues is consistently lower than normal tissues, and this is due to the both decrease of reduced nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FAD) lifetimes. A criterion line of lifetime at 1920<!--> <!-->ps can be given for differentiating human lung cancer and normal tissues.The sensitivity and specificity of FLIM for lung cancer diagnosis were determined as 92.9% and 92.3%. These findings suggest that NADH and FAD can be used to rapidly diagnose lung cancer. FLIM is a rapid, accurate and highly sensitive technique in the judgment during lung cancer surgery and it can be potential in earlier cancer detection.</p></div>","PeriodicalId":72344,"journal":{"name":"BBA clinical","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbacli.2017.04.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35047790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Alterations in antioxidant system, mitochondrial biogenesis and autophagy in preeclamptic myometrium","authors":"Polina A. Vishnyakova ,&nbsp;Maria A. Volodina ,&nbsp;Nadezhda V. Tarasova ,&nbsp;Maria V. Marey ,&nbsp;Natalya E. Kan ,&nbsp;Zulfiya S. Khodzhaeva ,&nbsp;Mikhail Yu. Vysokikh ,&nbsp;Gennady T. Sukhikh","doi":"10.1016/j.bbacli.2017.06.002","DOIUrl":"10.1016/j.bbacli.2017.06.002","url":null,"abstract":"<div><p>Preeclampsia is a pregnancy complication which causes significant maternal and fetal morbidity and mortality worldwide. Although intensive research has been performed in the last 40<!--> <!-->years, the pathology of preeclampsia is still poorly understood. The present work is a comparative study of the myometrium of women with normal pregnancy, and those with late- and early-onset preeclampsia (n<!--> <!-->=<!--> <!-->10 for each group). We observed significant changes in the levels of antioxidant enzymes, markers of mitochondrial biogenesis and autophagy proteins in preeclamptic myometrium. Levels of superoxide dismutase 1 and catalase were lower in both preeclamptic groups than the control group. In late-onset preeclampsia, expression levels of essential mitochondria-related proteins VDAC1, TFAM, hexokinase 1, PGC-1α and PGC-1β, and autophagy marker LC3A, were significantly elevated. In the myometrium of the early-onset preeclampsia group OPA1 and Bcl-2 were up-regulated compared to those of the control (p<!--> <!-->&lt;<!--> <!-->0.05). These findings suggest that crucial molecular changes in the maternal myometrium occur with the development of preeclampsia.</p></div>","PeriodicalId":72344,"journal":{"name":"BBA clinical","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbacli.2017.06.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35194995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Time resolved amplified FRET identifies protein kinase B activation state as a marker for poor prognosis in clear cell renal cell carcinoma","authors":"James Miles ,&nbsp;Christopher J. Applebee ,&nbsp;Pierre Leboucher ,&nbsp;Sonia Lopez-Fernandez ,&nbsp;Dae-Jin Lee ,&nbsp;Rosa Guarch ,&nbsp;Stephen Ward ,&nbsp;Peter J. Parker ,&nbsp;Jose I. López ,&nbsp;Banafshé Larijani","doi":"10.1016/j.bbacli.2017.10.002","DOIUrl":"10.1016/j.bbacli.2017.10.002","url":null,"abstract":"<div><h3>Purpose</h3><p>Clear cell Renal Cell Carcinomas (ccRCC), the largest group of renal tumours, are resistant to classical therapies. The determination of the functional state of actionable biomarkers for the assessment of these adenocarcinomas is essential. The dysregulation of the oncoprotein, PKB/Akt has been linked with poor prognoses in human cancers.</p></div><div><h3>Material &amp; methods</h3><p>We analysed the status of the PKB/Akt pathway in a representative tumour tissue microarray obtained from the primary tumours and their metastases in 60 ccRCC with long term follow up. We sought to define the evolution of this pathway from the primary tumour to the metastatic event and to know the impact of its functional state in tumour aggressiveness and patient survival. Two-site time resolved amplified FRET (A-FRET) was utilised for assessing the activation state of PKB/Akt and this was compared to conventional immunohistochemistry measurements.</p></div><div><h3>Results</h3><p>Activation state of PKB/Akt in primary tumours defined by A-FRET correlated with poorer overall survival (hazard ratio 0.228; <em>p</em> <!-->=<!--> <!-->0.002). Whereas, increased protein expression of phosphoPKB/Akt, identified using classical immunohistochemistry, yielded no significant difference (hazard ratio 1.390; <em>p</em> <!-->=<!--> <!-->0.548).</p></div><div><h3>Conclusions</h3><p>Quantitative determination of PKB/Akt activation in ccRCC primary tumours alongside other diagnostics tools could prove key in taking oncologists closer to an efficient personalised therapy in ccRCC patients.</p></div><div><h3>General significance</h3><p>The quantitative imaging technology based on Amplified-FRET can rapidly analyse protein activation states and molecular interactions. It could be used for prognosis and assess drug function during the early cycles of chemotherapy. It enables evaluation of clinical efficiency of personalised cancer treatment.</p></div>","PeriodicalId":72344,"journal":{"name":"BBA clinical","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbacli.2017.10.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35704845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Multiple exo-glycosidases in human serum as detected with the substrate DNP-α-GalNAc. II. Three α-N-acetylgalactosaminidase-like activities in the pH 5 to 8 region","authors":"Simon P.J. Albracht ,&nbsp;Johannes van Pelt","doi":"10.1016/j.bbacli.2017.09.002","DOIUrl":"https://doi.org/10.1016/j.bbacli.2017.09.002","url":null,"abstract":"<div><p>With the substrate DNP-α-GalNAc (2,4-dinitrophenyl-<em>N</em>-acetyl-α-<span>d</span>-galactosaminide) three α-<em>N</em>-acetylgalactosaminidase-like activities could be distinguished in serum, in addition to the classical lysosomal enzyme (Naga, EC 3.2.1.49, pH optimum at 4). Two activities had optima in the pH<!--> <!-->5 to 6 region and one peaked around pH<!--> <!-->8. Like the Naga activity at pH<!--> <!-->4, the activity at pH<!--> <!-->8 was detectable under standard assay conditions. However, the two activities in the pH<!--> <!-->5 to 6 range were not readily apparent in such assays. They could be unmasked as separate activities only when low serum concentrations were used. Addition of 1% saturated ammonium sulphate to the assay medium stimulated these activities. All activities in the pH<!--> <!-->5 to 8 range decreased with increasing serum concentration in the assay, suggesting the presence of endogenous inhibitors. The activities between pH<!--> <!-->5 and 6 might be similar to an activity described in 1996, which was considerably elevated in serum of patients with great variety of cancers (N. Yamamoto, V.R. Naraparaju, and S.O. Asbell (1996). Deglycosylation of serum vitamin D₃-binding protein leads to immunosuppression in cancer patients. Cancer Res. 56, 2827–2831).</p></div>","PeriodicalId":72344,"journal":{"name":"BBA clinical","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbacli.2017.09.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"92107043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Novel panel of protein biomarkers to predict response to bortezomib-containing induction regimens in multiple myeloma patients","authors":"Kay Reen Ting ,&nbsp;Michael Henry ,&nbsp;Justine Meiller ,&nbsp;Annemarie Larkin ,&nbsp;Martin Clynes ,&nbsp;Paula Meleady ,&nbsp;Despina Bazou ,&nbsp;Paul Dowling ,&nbsp;Peter O'Gorman","doi":"10.1016/j.bbacli.2017.05.003","DOIUrl":"10.1016/j.bbacli.2017.05.003","url":null,"abstract":"<div><h3>Background</h3><p>Multiple myeloma (MM) is a complex heterogeneous disease. Various risk stratification models have been recommended including cytogenetic and FISH analysis to identify high-risk patients who may benefit from novel treatments, but such facilities are not widely available. The International Scoring System (ISS) using beta-2-microglobulin and albumin remains a widely used prognostic scoring system in many clinical practices; however it is not useful in predicting response to treatment in MM. The aim of this study is to identify clinically useful biomarkers to predict response to treatment containing bortezomib.</p></div><div><h3>Methods</h3><p>17 MM patient serum samples (9 responders/8 non-responders) were used for the discovery phase (label-free mass spectrometry) and an additional 20 MM patient serum samples were used for the ELISA-based validation phase (14 responders/6 non-responders).</p></div><div><h3>Results</h3><p>CLU and ANG mean levels were higher in the responders group, while Complement C1q had lower concentrations. The combination of all standard biomarkers (albumin, beta-2-microglobulin (ß2M), paraprotein and kappa/lambda (K/L) ratio) had an AUC value of 0.71 with 65% correct classification, while an overall combination of new candidate protein biomarkers with standard biomarkers had an AUC value of 0.89 with 85.3% correct classification.</p></div><div><h3>Conclusions</h3><p>A combination of new and standard biomarkers consisting of CLU, ANG, C1Q, albumin, ß2M, paraprotein and K/L ratio may have potential as a novel panel of biomarkers to predict MM response to treatment containing bortezomib.</p></div><div><h3>General significance</h3><p>Use of this biomarker panel could facilitate a more personalized therapy approach and to minimize unnecessary side effects from ineffective drugs.</p></div>","PeriodicalId":72344,"journal":{"name":"BBA clinical","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbacli.2017.05.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35182675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Spontaneous miscarriage in first trimester pregnancy is associated with altered urinary metabolite profile","authors":"Chee Wai Ku ,&nbsp;Zhen Wei Tan ,&nbsp;Mark Kit Lim ,&nbsp;Zhi Yang Tam ,&nbsp;Chih-Hsien Lin ,&nbsp;Sean Pin Ng ,&nbsp;John Carson Allen ,&nbsp;Sze Min Lek ,&nbsp;Thiam Chye Tan ,&nbsp;Nguan Soon Tan","doi":"10.1016/j.bbacli.2017.07.003","DOIUrl":"10.1016/j.bbacli.2017.07.003","url":null,"abstract":"<div><p>Threatened miscarriage is the most common gynecological emergency, occurring in about 20% of pregnant women. Approximately one in four of these patients go on to have spontaneous miscarriage and the etiology of miscarriage still remains elusive. In a bid to identify possible biomarkers and novel treatment targets, many studies have been undertaken to elucidate the pathways that lead to a miscarriage. Luteal phase deficiency has been shown to contribute to miscarriages, and the measurement of serum progesterone as a prognostic marker and the prescription of progesterone supplementation has been proposed as possible diagnostic and treatment methods. However, luteal phase deficiency only accounts for 35% of miscarriages. In order to understand the other causes of spontaneous miscarriage and possible novel urine biomarkers for miscarriage, we looked at the changes in urinary metabolites in women with threatened miscarriage. To this end, we performed a case-control study of eighty patients who presented with threatened miscarriage between 6 and 10<!--> <!-->weeks gestation. Urine metabolomics analyses of forty patients with spontaneous miscarriages and forty patients with ongoing pregnancies at 16<!--> <!-->weeks gestation point to an impaired placental mitochondrial β-oxidation of fatty acids as the possible cause of spontaneous miscarriage. This study also highlighted the potential of urine metabolites as a non-invasive screening tool for the risk stratification of women presenting with threatened miscarriage.</p></div>","PeriodicalId":72344,"journal":{"name":"BBA clinical","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbacli.2017.07.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35380961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Body mass index is associated with region-dependent metabolic reprogramming of adipose tissue","authors":"Marco G. Alves ,&nbsp;Ângela Moreira ,&nbsp;Marta Guimarães ,&nbsp;Mário Nora ,&nbsp;Mario Sousa ,&nbsp;Pedro F. Oliveira ,&nbsp;Mariana P. Monteiro","doi":"10.1016/j.bbacli.2017.05.001","DOIUrl":"10.1016/j.bbacli.2017.05.001","url":null,"abstract":"<div><p>Adipose tissue (AT) is involved in dysmetabolism pathogenesis. Regional fat distribution and functioning may contribute to obesity-related metabolic disorders and adverse health outcomes. Specific fat depots are suggested to possess unique biological properties, but specific metabolic profiles of subcutaneous (SAT) and visceral adipose tissue (VAT) remain unknown. We aimed to characterize VAT and SAT glucose metabolism, and their correlation with body mass index (BMI). AT samples from patients (n<!--> <!-->=<!--> <!-->12; F:M, 9:3) with a mean age of 46<!--> <!-->years (26–83<!--> <!-->years) and an average BMI of 29.6<!--> <!-->kg/m² (18–37<!--> <!-->kg/m²) were used. VAT and SAT explants were obtained during elective laparoscopy, either cholecystectomy for uncomplicated cholelithiasis or gastric bypass for severe obesity. Explants were placed in insulin-free cell culture media and their metabolic profile was established by proton nuclear magnetic resonance. AT explants display a glucose and pyruvate consumption and acetate production that is region-dependent according to the patients BMI. In VAT, glucose consumption was positively correlated with BMI, while alanine and lactate production were negatively correlated with BMI, whereas in SAT the patients BMI did not affect AT secretome suggesting that increased BMI promotes a metabolic reprogramming of VAT towards de novo lipogenesis. This region-dependent metabolic reprogramming of AT associated with BMI was autonomous of insulin. This data, although preliminary, suggests that there is a BMI-related remodeling of glucose metabolism in VAT. Targeting this BMI-induced metabolic shift may represent a potential target to counteract unwanted consequences derived from visceral adiposity.</p></div>","PeriodicalId":72344,"journal":{"name":"BBA clinical","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbacli.2017.05.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35047789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}